Horgan, A M <br/><br/>
Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trial.  [electronic resource] 

 -  Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus  Nov 2016 
 - 1152-1158 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1442-2050 
<br/><br/><label>Standard No.: </label>10.1111/dote.12444  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Chemoradiotherapy<br/>Chemotherapy, Adjuvant--mortality<br/>Cisplatin--administration & dosage<br/>Esophageal Neoplasms--mortality<br/>Esophagectomy<br/>Esophagogastric Junction--pathology<br/>Feasibility Studies<br/>Female<br/>Humans<br/>Indoles--administration & dosage<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Neoplasm Recurrence, Local--mortality<br/>Neoplasm Staging<br/>Postoperative Period<br/>Pyrroles--administration & dosage<br/>Sunitinib<br/>Survival Rate<br/>Withholding Treatment--statistics & numerical data